MMP2 and breast carcinoma: Low TIMP-2 levels in the blood of breast carcinoma patients could indicate more activated MMP-2 and therefore higher usage of TIMP-2, or alternatively, the lower levels could be due to lower production of TIMP-2, leading to lesser inhibition of MMP-2 activity.